Decentralization Dilemma – Why Diagnostic OEMs Must Redefine Relevance?
HPV Self-Sampling & Diagnostic Decentralization Business Hypothesis: As self-sampling and decentralized screening become mainstream, diagnostic value will migrate from centralized assay throughput to distributed patient participation. Traditional OEM business models, which rely on reagent volume, lab automation, and service lock-ins, continue to face the risk of economic erosion unless they redefine how and where they […]
How Fatal Can Be Medical Device Biases For Human Life?
Some pandemics last a few years, while others continue to evolve into more lethal forms, causing ever-increasing damage. The case of medical device biases is one of those everlasting pandemics. We can thank COVID-19 for bestowing the issue with the needed limelight. According to a recent estimate, healthcare-based racial disparities cost $93 billion in extended […]